Cardiomyopathy
Research from Emory University, Medical Department provide new insights into cardiomyopathy
Published in Cardiovascular Device Liability Week, August 24th, 2008
"Point mutations in POLG and TK2 result in clinical diseases associated with mtDNA depletion and organ dysfunction. Pyrimidine analogs (NRTIs) inhibit Pol gamma and mtDNA replication. Cardiac ''dominant negative'' murine transgenes (TGs; Pol gamma Y955C, and TK2 H121N or I212N) defined the role of each in the heart. mtDNA abundance, histopathological features, histochemistry, mitochondrial protein abundance,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Device Liability Week
More Articles from Cardiovascular Device Liability Week
- Abdominal Aortic Aneurysm
Study data from University of Verona update understanding of abdominal aortic aneurysm - Abiomed, Inc.
Abiomed Announces Impella 2.5 Capacity Expansion Plans in Ireland - Acorda Therapeutics
Acorda Therapeutics Presents Positive Data from Preclinical Studies of Neuregulins in Cardiac Function - Acute Ischemia
Researchers from Indiana University report details of new studies and findings in the area of acute ischemia - Acute Leukemia Therapy
Investigators at Charles University, Department of Medicine release new data on acute leukemia therapy - Acute Myeloid Leukemia
Researchers from Charles University discuss findings in acute myeloid leukemia - More from this issue of Cardiovascular Device Liability Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
